December 4, 2011 - 16:42 AMT
PanARMENIAN.Net - At present, Armenia’s pharmaceutical production can meet only 8% of total customer demand in the country, the chairman of NA Standing Committee on Social Affairs, Health Care and Environmental Protection said, stressing the necessity for the development of the sector in the country.
In view of growing demand for pharmaceuticals, increase of production volume to USD 35 mln against 8,8 mln in 2010 is planned, with export volume to grow to USD 25 mln against 5 mln in 2010; jobs in relevant sector will increase to 1800 against 550 in 2010.
As of today, Armenia-manufactured pharmaceuticals are exported to the following markets: Georgia- 38%, Russia – 18%, Uzbekistan – 13%, Belarus – 6%, Ukraine – 5%, Qatar – 4%.
At the seminar on export-oriented industrial development strategy, Ara Babloyan noted raw material supply, distribution and storage as problematic issues. However, he said, Armenia prides itself on having been the first CIS state to have founded a quality control laboratory to guarantee high quality medications entry to Armenian market of pharmaceuticals. Also, the official noted, implementation of international standards staring Jan 1, 2013 will allow for increase of export production.
On December 4, TUMO center for creative technologies is hosting a seminar on export-oriented industrial development strategy, with representatives of government structures, entrepreneurs and politicians attending.